StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
14
Publishing Date
2023 - 11 - 07
1
2021 - 07 - 23
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 09
1
2021 - 05 - 24
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
2021 - 03 - 25
1
2021 - 03 - 19
1
2021 - 03 - 11
1
Sector
Health technology
14
Tags
Biotech-beach
1
Financial
1
N/a
13
Results
1
Entities
3m company
8
Abbott laboratories
37
Abbvie inc.
165
Abcam plc
7
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
9
Adc therapeutics sa
8
Agios pharmaceuticals, inc.
12
Alibaba group holding limited
7
Alico, inc.
7
Alnylam pharmaceuticals, inc.
11
Amgen inc.
742
Astellas pharma inc
31
Astrazeneca plc
106
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
19
Baxter international inc.
22
Becton, dickinson and company
9
Beigene, ltd.
117
Biocryst pharmaceuticals, inc.
13
Biogen inc.
49
Biomarin pharmaceutical inc.
8
Blueprint medicines corporation
12
Bristol-myers squibb company
86
Chemocentryx, inc.
51
Clovis oncology, inc.
10
Credit suisse group
8
Credit suisse group ag
8
Eli lilly and company
88
Entera bio ltd.
35
Epizyme, inc.
10
Exelixis, inc.
12
Genmab a/s
11
Gilead sciences, inc.
35
Glaxosmithkline plc
110
Illumina, inc.
15
Incyte corporation
12
Intel corporation
8
Johnson & johnson
94
Karyopharm therapeutics inc.
12
Medtronic plc
17
Morgan stanley
10
Norfolk southern corporation
10
Novartis ag
196
Novo nordisk a/s
17
Omeros corporation
14
Orchard therapeutics plc
8
Otonomy, inc.
14
Pfizer, inc.
34
Regeneron pharmaceuticals, inc.
27
Rigel pharmaceuticals, inc.
11
Sanofi
170
Takeda pharmaceutical company limited
23
Teva pharmaceutical industries ltd
83
Thermo fisher scientific inc
21
Ucb s.a.
10
Verastem, inc.
10
Viatris inc.
37
Xeris pharmaceuticals, inc.
11
Y-mabs therapeutics, inc.
11
Symbols
ABBV
13
AGEN
1
AMGN
14
BCRX
13
BMRN
3
BMY
13
BNTX
2
CALT
3
DTIL
1
FNCTF
1
GILD
14
IMGN
1
INAB
1
INCY
2
JNJ
1
KDNY
1
LLY
15
MCRB
1
MNKD
1
MOR
1
MPSYF
1
MRKR
1
MTEM
1
NVS
1
NVSEF
1
OMER
81
OTIC
13
PFE
13
REGN
6
SCYX
1
SGEN
1
SNY
15
SNYNF
2
SPPI
1
SRNE
1
SUPN
3
TVTX
1
VTVT
1
XERS
10
XNCR
2
ZYME
1
Exchanges
Nasdaq
14
Nyse
13
Crawled Date
2023 - 11 - 08
1
2021 - 07 - 27
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 09
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
1
2021 - 03 - 25
1
2021 - 03 - 19
1
2021 - 03 - 11
1
Crawled Time
00:00
5
10:51
1
12:34
1
13:07
1
13:17
1
13:27
1
14:03
1
15:49
1
17:43
1
18:32
1
Source
www.biospace.com
1
www.fda.gov
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Omeros corporation
symbols :
AMGN
save search
Xencor Reports Third Quarter 2023 Financial Results
Published:
2023-11-07
(Crawled : 00:00)
- biospace.com/
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
3.64%
|
O:
-0.05%
H:
1.41%
C:
0.82%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
145.59%
|
O:
-1.47%
H:
11.57%
C:
5.97%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
119.05%
|
O:
0.36%
H:
0.48%
C:
-1.09%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-17.55%
|
O:
-0.09%
H:
0.35%
C:
-0.57%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.89%
|
O:
0.05%
H:
0.38%
C:
-0.68%
financial
results
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-07-23
(Crawled : 00:00)
- fda.gov
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
Email alert
Add to watchlist
SCYX
|
$1.44
2.49%
2.43%
130K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-24
(Crawled : 14:03)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-34.9%
|
O:
0.23%
H:
0.52%
C:
0.13%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
245.82%
|
O:
8.21%
H:
1.89%
C:
-0.83%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.99%
|
O:
0.31%
H:
1.15%
C:
0.6%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
44.88%
|
O:
0.37%
H:
1.55%
C:
0.28%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-54.87%
|
O:
0.0%
H:
10.77%
C:
10.77%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.62%
|
O:
0.29%
H:
0.8%
C:
0.17%
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-78.38%
|
O:
0.32%
H:
0.87%
C:
0.26%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
0.38%
|
O:
0.18%
H:
2.2%
C:
0.61%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-73.51%
|
O:
0.06%
H:
0.35%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
10.99%
|
O:
0.71%
H:
1.09%
C:
0.22%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-34.5%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
243.52%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.34%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
46.0%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-57.18%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.9%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-77.82%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
0.44%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-71.68%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
11.0%
|
O:
0.4%
H:
0.53%
C:
0.25%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-09
(Crawled : 10:51)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-34.57%
|
O:
0.39%
H:
2.15%
C:
2.08%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
240.18%
|
O:
0.29%
H:
2.43%
C:
2.1%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.18%
|
O:
0.5%
H:
2.39%
C:
2.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
47.02%
|
O:
0.48%
H:
1.36%
C:
0.99%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-54.87%
|
O:
7.18%
H:
4.52%
C:
-4.07%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.58%
|
O:
0.88%
H:
0.74%
C:
0.5%
OTIC
|
$0.077
|
Health Technology
|
-96.75%
|
O:
-0.84%
H:
5.93%
C:
0.42%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-78.93%
|
O:
0.95%
H:
2.0%
C:
0.25%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-0.9%
|
O:
0.09%
H:
2.4%
C:
1.6%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-73.59%
|
O:
0.82%
H:
2.39%
C:
-1.11%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
11.87%
|
O:
0.46%
H:
1.42%
C:
0.67%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-24
(Crawled : 00:00)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-36.37%
|
O:
0.33%
H:
0.15%
C:
-0.67%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
275.61%
|
O:
0.56%
H:
1.3%
C:
0.01%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.96%
|
O:
0.33%
H:
1.03%
C:
0.03%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
42.23%
|
O:
0.4%
H:
0.19%
C:
-0.58%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-49.28%
|
O:
-1.15%
H:
1.46%
C:
-4.66%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.44%
|
O:
0.02%
H:
0.3%
C:
-0.3%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
77.85%
|
O:
0.6%
H:
0.0%
C:
-1.82%
OTIC
|
$0.077
|
Health Technology
|
-96.87%
|
O:
1.21%
H:
0.0%
C:
-7.2%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-77.57%
|
O:
0.94%
H:
1.4%
C:
1.06%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-2.69%
|
O:
0.51%
H:
0.2%
C:
-2.42%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-67.53%
|
O:
0.43%
H:
1.44%
C:
-2.16%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
5.55%
|
O:
-0.18%
H:
1.17%
C:
-1.12%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-18
(Crawled : 13:27)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-36.62%
|
O:
0.17%
H:
0.41%
C:
-0.32%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
283.97%
|
O:
-0.27%
H:
0.69%
C:
-0.19%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.21%
|
O:
-0.06%
H:
0.58%
C:
0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
41.3%
|
O:
-0.67%
H:
1.54%
C:
0.95%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-49.43%
|
O:
0.0%
H:
5.46%
C:
3.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.92%
|
O:
0.22%
H:
0.1%
C:
-0.26%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
72.07%
|
O:
-0.14%
H:
0.0%
C:
-1.3%
OTIC
|
$0.077
|
Health Technology
|
-96.73%
|
O:
-0.84%
H:
4.63%
C:
1.7%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-81.23%
|
O:
0.06%
H:
1.35%
C:
-0.06%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-3.14%
|
O:
0.49%
H:
0.66%
C:
-0.81%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-68.71%
|
O:
-0.76%
H:
4.91%
C:
0.77%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
4.97%
|
O:
-0.12%
H:
0.4%
C:
-0.48%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-12
(Crawled : 17:43)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-35.4%
|
O:
0.23%
H:
1.22%
C:
0.63%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
285.5%
|
O:
0.0%
H:
0.46%
C:
-0.8%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.84%
|
O:
0.26%
H:
1.24%
C:
0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
43.75%
|
O:
-0.03%
H:
1.0%
C:
0.1%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-48.54%
|
O:
-2.68%
H:
7.56%
C:
0.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.4%
|
O:
-0.46%
H:
0.95%
C:
0.12%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
79.81%
|
O:
-0.84%
H:
3.35%
C:
2.04%
OTIC
|
$0.077
|
Health Technology
|
-96.28%
|
O:
1.92%
H:
4.25%
C:
1.42%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-81.88%
|
O:
-1.41%
H:
2.86%
C:
-1.76%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-0.48%
|
O:
-0.7%
H:
1.8%
C:
1.05%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-62.93%
|
O:
-1.98%
H:
6.47%
C:
4.96%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
5.01%
|
O:
-0.35%
H:
0.92%
C:
-0.23%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-22
(Crawled : 12:34)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-35.69%
|
O:
-0.13%
H:
0.05%
C:
-2.13%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
293.18%
|
O:
-0.5%
H:
0.67%
C:
-1.55%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.17%
|
O:
-0.26%
H:
0.62%
C:
0.26%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
49.06%
|
O:
-0.14%
H:
0.4%
C:
-0.54%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-54.64%
|
O:
0.26%
H:
4.37%
C:
-0.26%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.25%
|
O:
-0.93%
H:
0.27%
C:
0.17%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
77.93%
|
O:
-0.21%
H:
0.0%
C:
-2.96%
OTIC
|
$0.077
|
Health Technology
|
-96.61%
|
O:
0.0%
H:
3.51%
C:
0.88%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-82.54%
|
O:
0.1%
H:
0.31%
C:
-3.03%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
0.16%
|
O:
-0.46%
H:
0.05%
C:
-1.26%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-61.41%
|
O:
-0.34%
H:
8.09%
C:
3.7%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
2.38%
|
O:
-0.48%
H:
0.36%
C:
-0.97%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-20
(Crawled : 13:17)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-34.7%
|
O:
-0.46%
H:
1.26%
C:
0.72%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
295.89%
|
O:
0.41%
H:
1.62%
C:
0.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.37%
|
O:
-0.23%
H:
1.65%
C:
0.96%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
52.07%
|
O:
-0.45%
H:
1.33%
C:
0.84%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-52.82%
|
O:
-0.8%
H:
3.24%
C:
2.97%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.18%
|
O:
-0.08%
H:
0.42%
C:
0.42%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
80.35%
|
O:
-0.03%
H:
1.44%
C:
0.97%
OTIC
|
$0.077
|
Health Technology
|
-96.68%
|
O:
0.0%
H:
0.86%
C:
-1.72%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-81.53%
|
O:
-0.83%
H:
4.52%
C:
3.46%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
1.44%
|
O:
-0.23%
H:
1.22%
C:
0.88%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-60.9%
|
O:
-0.17%
H:
3.22%
C:
-3.31%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
3.5%
|
O:
-0.44%
H:
2.17%
C:
1.69%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-12
(Crawled : 00:00)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-30.55%
|
O:
-0.33%
H:
1.52%
C:
1.34%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
306.94%
|
O:
-0.57%
H:
0.28%
C:
-0.88%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-22.86%
|
O:
-0.13%
H:
0.39%
C:
0.26%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
53.58%
|
O:
0.26%
H:
0.7%
C:
0.4%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-58.39%
|
O:
-0.47%
H:
0.12%
C:
-6.65%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.36%
|
O:
-0.33%
H:
0.12%
C:
-0.69%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
89.66%
|
O:
1.39%
H:
0.0%
C:
-1.86%
OTIC
|
$0.077
|
Health Technology
|
-96.53%
|
O:
0.0%
H:
0.9%
C:
-0.45%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-81.68%
|
O:
0.0%
H:
0.0%
C:
-7.13%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.75%
|
O:
-0.08%
H:
0.08%
C:
-0.61%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-55.93%
|
O:
-0.59%
H:
0.1%
C:
-6.4%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
6.42%
|
O:
-0.17%
H:
0.6%
C:
0.17%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-25
(Crawled : 15:49)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-28.62%
|
O:
0.11%
H:
0.39%
C:
0.06%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
316.7%
|
O:
0.46%
H:
1.46%
C:
1.15%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-22.47%
|
O:
1.12%
H:
0.0%
C:
-0.33%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
60.26%
|
O:
-0.16%
H:
1.21%
C:
0.95%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
14.79%
|
O:
-0.32%
H:
5.23%
C:
4.43%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.26%
|
O:
0.89%
H:
0.5%
C:
0.41%
OTIC
|
$0.077
|
Health Technology
|
-97.09%
|
O:
-1.88%
H:
2.3%
C:
0.0%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-82.83%
|
O:
-1.44%
H:
3.5%
C:
2.24%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
3.96%
|
O:
0.67%
H:
0.15%
C:
-1.22%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
21.89%
|
O:
-0.72%
H:
1.06%
C:
0.76%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-57.26%
|
O:
-4.08%
H:
7.03%
C:
6.04%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
7.93%
|
O:
0.64%
H:
0.2%
C:
-0.32%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-19
(Crawled : 18:32)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-11
(Crawled : 13:07)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-27.23%
|
O:
0.4%
H:
0.14%
C:
-1.03%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
265.43%
|
O:
0.52%
H:
0.36%
C:
-0.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-20.73%
|
O:
0.11%
H:
0.31%
C:
-1.07%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
52.93%
|
O:
0.12%
H:
0.46%
C:
-0.24%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
12.03%
|
O:
0.12%
H:
3.37%
C:
3.33%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.09%
|
O:
-0.31%
H:
0.63%
C:
0.08%
OTIC
|
$0.077
|
Health Technology
|
-97.21%
|
O:
1.81%
H:
2.48%
C:
1.42%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-82.53%
|
O:
2.46%
H:
1.25%
C:
0.36%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
4.68%
|
O:
-0.63%
H:
0.83%
C:
-0.66%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
17.6%
|
O:
0.28%
H:
1.23%
C:
-0.35%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-66.94%
|
O:
1.62%
H:
0.65%
C:
-6.07%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
15.21%
|
O:
0.3%
H:
1.43%
C:
0.22%
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.